Reference-mean-centered statistical quality control
-
Martín Yago
und
Carolina Pla
Abstract
Background
Statistical quality control (SQC) procedures generally use rejection limits centered on the stable mean of the results obtained for a control material by the analyzing instrument. However, for instruments with significant bias, re-centering the limits on a different value could improve the control procedures from the viewpoint of patient safety.
Methods
A statistical model was used to assess the effect of shifting the rejection limits of the control procedure relative to the instrument mean on the number of erroneous results reported as a result of an increase in the systematic error of the measurement procedure due to an out-of-control condition. The behaviors of control procedures of type 1ks (k = 2, 2.5, 3) were studied when applied to analytical processes with different capabilities (σ = 3, 4, 6).
Results
For measuring instruments with bias, shifting the rejection limits in the direction opposite to the bias improves the ability of the quality control procedure to limit the risk posed to patients in a systematic out-of-control condition. The maximum benefit is obtained when the displacement is equal to the bias of the instrument, that is, when the rejection limits are centered on the reference mean of the control material. The strategy is sensitive to error in estimating the bias. Shifting the limits more than the instrument’s bias disproportionately increases the risk to patients. This effect should be considered in SQC planning for systems running the same test on multiple instruments.
Conclusions
Centering the control rule on the reference mean is a potentially useful strategy for SQC planning based on risk management for measuring instruments with significant and stable uncorrected bias. Low uncertainty in estimating bias is necessary for this approach not to be counterproductive.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Parvin CA, Kuchipudi L, Yundt-Pacheco J. Designing QC rules in the presence of laboratory bias: should a QC rule be centered on the instrument’s mean or the reference mean? https://www.qcnet.com/Portals/0/Events/AACC%20Abst%20Poster%202012.pdf. Accessed: August 2019.Suche in Google Scholar
2. Parvin CA. Assessing the impact of the frequency of quality control testing on the quality of reported patient results. Clin Chem 2008;54:2049–54.10.1373/clinchem.2008.113639Suche in Google Scholar PubMed
3. Yago M. Selecting statistical quality control procedures for limiting the impact of increases in analytical random error on patient safety. Clin Chem 2017;63:1022–30.10.1373/clinchem.2016.267682Suche in Google Scholar PubMed
4. Ye JJ, Ingels SC, Parvin CA. Performance evaluation and planning for patient-based quality control procedures. Am J Clin Pathol 2000;113:240–8.10.1309/V5BT-BAWP-1WBF-14W6Suche in Google Scholar PubMed
5. Theodorsson E, Magnusson B, Leito I. Bias in clinical chemistry. Bioanalysis 2014;6:2855–75.10.4155/bio.14.249Suche in Google Scholar PubMed
6. Becker D, Christensen R, Currie L, Diamondstone B, Eberhardt K, Gills T, et al. Use of NIST standard reference materials for decisions on performance of analytical chemical methods and laboratories; 1992. www.nist.gov/mml/csd/inorganic/upload/NIST_SpecialPub829.pdf. Accessed: November 2019.10.6028/NIST.SP.829Suche in Google Scholar
7. Yago M, Alcover S. Selecting statistical procedures for quality control planning based on risk management. Clin Chem 2016;62:959–65.10.1373/clinchem.2015.254094Suche in Google Scholar PubMed
8. Jones G, Calleja J, Chesher D, Parvin C, Yundt-Pacheco J, MackayM, et al. Collective Opinion Paper on 2013 AACB Workshop of Experts seeking Harmonisation of Approaches to Setting a Laboratory Quality Control Policy. Clin Biochem Rev 2015;36:87–95.Suche in Google Scholar
9. Johnston A, Bourner G, Martin T, McFarlane A, Good D, Padmore R, et al. Guidance for quality control practices and precision goals for CBCs based on IQMH patterns-of-practice survey. Int J Lab Hematol 2019;41:15–22.10.1111/ijlh.12915Suche in Google Scholar PubMed
10. Badrick T, Turner P. How should the QC targets be set with common analytes on multiple instruments? https://www.aacb.asn.au/documents/item/3084. Accessed: September 2019.Suche in Google Scholar
11. Kuchipudi LS, Yundt-Pacheco JC, Parvin CA. Designing QC rules for multiple instruments: should a QC rule be centered on individual instrument means or on a fixed mean? Should the limits be based on individual instrument SDs or a fixed SD? https://www.qcnet.com/LinkClick.aspx?fileticket=Jf3SU-9BKmg%3D&portalid=0. Accessed: September 2019.Suche in Google Scholar
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2019-1034).
©2020 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Editorial
- Measurement uncertainty: light in the shadows
- Review
- Childhood obesity: an overview of laboratory medicine, exercise and microbiome
- Mini review
- The utility of measurement uncertainty in medical laboratories
- Opinion Paper
- Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
- Opinion Papers
- The current status and future prospects of precision medicine
- Precision medicine in medical oncology: hope, disappointment and reality
- IFCC Papers
- Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey
- Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey
- Genetics and Molecular Diagnostics
- Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples
- General Clinical Chemistry and Laboratory Medicine
- Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient
- Isotope dilution-LC-MS/MS method for quantification of the urinary cotinine-to-creatinine ratio
- A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders
- Assessment of antinuclear antibodies by indirect immunofluorescence assay: report from a survey by the American Association of Medical Laboratory Immunologists
- Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis
- Reference Values and Biological Variations
- Continuous, complete and comparable NT-proBNP reference ranges in healthy children
- Reference-mean-centered statistical quality control
- Hematology and Coagulation
- Top-down and bottom-up approaches for the estimation of measurement uncertainty in coagulation assays
- Cancer Diagnostics
- Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer
- Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma
- Cardiovascular Diseases
- Establishing the 99th percentile of a novel assay for high-sensitivity troponin I in a healthy blood donor population
- The clinically effective use of cardiac markers by restructuring laboratory profiles at Cardiology wards
- Infectious Diseases
- Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital
- SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
- Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing
- Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
- Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays
- Letters to the Editor
- Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China
- Blood sampling after COVID-19 − How to organize large scale phlebotomy services in the post SARS CoV-2 era
- Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department
- Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19)
- Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients – a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China
- Low levels of total and ionized calcium in blood of COVID-19 patients
- Is “light cannabis” really light? Determination of cannabinoids content in commercial products
- Amino-terminal proB-type natriuretic peptide reference values in umbilical cord blood
- The new era of LED microscopes in immunofluorescence anti-nuclear antibody (ANA) testing
- The centrifuge brake impacts neither routine coagulation assays nor platelet count in platelet-poor plasma
Artikel in diesem Heft
- Frontmatter
- Editorial
- Measurement uncertainty: light in the shadows
- Review
- Childhood obesity: an overview of laboratory medicine, exercise and microbiome
- Mini review
- The utility of measurement uncertainty in medical laboratories
- Opinion Paper
- Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
- Opinion Papers
- The current status and future prospects of precision medicine
- Precision medicine in medical oncology: hope, disappointment and reality
- IFCC Papers
- Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey
- Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey
- Genetics and Molecular Diagnostics
- Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples
- General Clinical Chemistry and Laboratory Medicine
- Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient
- Isotope dilution-LC-MS/MS method for quantification of the urinary cotinine-to-creatinine ratio
- A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders
- Assessment of antinuclear antibodies by indirect immunofluorescence assay: report from a survey by the American Association of Medical Laboratory Immunologists
- Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis
- Reference Values and Biological Variations
- Continuous, complete and comparable NT-proBNP reference ranges in healthy children
- Reference-mean-centered statistical quality control
- Hematology and Coagulation
- Top-down and bottom-up approaches for the estimation of measurement uncertainty in coagulation assays
- Cancer Diagnostics
- Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer
- Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma
- Cardiovascular Diseases
- Establishing the 99th percentile of a novel assay for high-sensitivity troponin I in a healthy blood donor population
- The clinically effective use of cardiac markers by restructuring laboratory profiles at Cardiology wards
- Infectious Diseases
- Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital
- SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
- Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing
- Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
- Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays
- Letters to the Editor
- Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China
- Blood sampling after COVID-19 − How to organize large scale phlebotomy services in the post SARS CoV-2 era
- Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department
- Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19)
- Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients – a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China
- Low levels of total and ionized calcium in blood of COVID-19 patients
- Is “light cannabis” really light? Determination of cannabinoids content in commercial products
- Amino-terminal proB-type natriuretic peptide reference values in umbilical cord blood
- The new era of LED microscopes in immunofluorescence anti-nuclear antibody (ANA) testing
- The centrifuge brake impacts neither routine coagulation assays nor platelet count in platelet-poor plasma
